Literature DB >> 24712488

Effect of rikkunshito on the expression of substance P and CGRP in dorsal root ganglion neurons and voluntary movement in rats with experimental reflux esophagitis.

T Kondo1, T Oshima, J Koseki, T Hattori, Y Kase, T Tomita, H Fukui, J Watari, H Miwa.   

Abstract

BACKGROUND: While there are reports that the herbal medicine rikkunshito (RKT) relieves upper gastrointestinal disease symptoms, the effect of RKT on primary afferent neurons is unknown.
METHODS: A model of reflux esophagitis (RE) was implemented using male Wistar rats aged 6-7 weeks. Ten days after surgery, the total area of esophageal mucosal erosion sites was determined. Th8-10 dorsal root ganglia (DRG) were dissected out and the expression of substance P (SP), calcitonin gene-related peptide (CGRP), and phosphorylated extracellular signal-regulated kinase 1/2 (p-ERK1/2) was determined in DRG using immunohistochemistry. RKT (0.6%/WV) or omeprazole (OME) (10 mg/kg) was administered for 10 days beginning on the day after surgery. Voluntary movement was measured with an infrared sensor for 22 h each day. KEY
RESULTS: RE rats showed esophageal mucosal erosion and significantly increased number of SP/CGRP- and p-ERK1/2-immunoreactive neurons in DRG. Treatment with OME improved the size of erosive lesions in the esophageal mucosa of RE rats, while RKT did not. Treatment with RKT or OME significantly reduced the expression of SP/CGRP and p-ERK1/2 in DRG, and significantly increased voluntary movement in RE rats. CONCLUSIONS & INFERENCES: RKT inhibited the activation of ERK1/2 and decreased the expression of SP and CGRP in DRG of RE rats, which may be associated with the observed amelioration of voluntary movement.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  CGRP; DRG; ERK1/2; Rikkunshito; SP

Mesh:

Substances:

Year:  2014        PMID: 24712488     DOI: 10.1111/nmo.12342

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  6 in total

1.  A novel prostanoid EP1 receptor antagonist, ONO-8539, reduces acid-induced heartburn symptoms in healthy male volunteers: a randomized clinical trial.

Authors:  Takashi Kondo; Hiroo Sei; Takahisa Yamasaki; Toshihiko Tomita; Yoshio Ohda; Tadayuki Oshima; Hirokazu Fukui; Jiro Watari; Hiroto Miwa
Journal:  J Gastroenterol       Date:  2017-01-24       Impact factor: 7.527

2.  Clinical application of kampo medicine (rikkunshito) for common and/or intractable symptoms of the gastrointestinal tract.

Authors:  Kazunari Tominaga; Tetsuo Arakawa
Journal:  Front Pharmacol       Date:  2015-01-30       Impact factor: 5.810

Review 3.  Nervous mechanisms of restraint water-immersion stress-induced gastric mucosal lesion.

Authors:  Dong-Qin Zhao; Hua Xue; Hai-Ji Sun
Journal:  World J Gastroenterol       Date:  2020-05-28       Impact factor: 5.742

4.  Circulating Levels of Calcitonin Gene-Related Peptide Are Lower in COVID-19 Patients.

Authors:  Laura Ochoa-Callejero; Josune García-Sanmartín; Pablo Villoslada-Blanco; María Íñiguez; Patricia Pérez-Matute; Elisabet Pujadas; Mary E Fowkes; Rachel Brody; José A Oteo; Alfredo Martínez
Journal:  J Endocr Soc       Date:  2021-01-04

5.  Suppression of neuropeptide production by quercetin in allergic rhinitis model rats.

Authors:  Misako Kashiwabara; Kazuhito Asano; Tomomi Mizuyoshi; Hitome Kobayashi
Journal:  BMC Complement Altern Med       Date:  2016-05-20       Impact factor: 3.659

6.  Whole genome gene expression changes and hematological effects of rikkunshito in patients with advanced non-small cell lung cancer receiving first line chemotherapy.

Authors:  Yung-Che Chen; An-Shen Lin; Yu-Chiang Hung; Kuang-Den Chen; Ching-Yuan Wu; Chien-Hao Lie; Chang-Chun Hsiao; Chung-Jen Chen; Shih-Feng Liu; Wen-Feng Fang; Jen-Chieh Chang; Ting-Ya Wang; Yi-Hsi Wang; Yu-Hsiu Chung; Tung-Ying Chao; Sum-Yee Leung; Mao-Chang Su; Meng-Chih Lin
Journal:  Exp Ther Med       Date:  2017-07-11       Impact factor: 2.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.